(:RMED)

Business Focus: N/A

Aug 17, 2023 08:00 am ET

Reminder: Ra Medical Systems Announces Name and Ticker Symbol Changes

Name change to Catheter Precision, Inc. is effective on August 17, 2023, with trading under new ticker symbol VTAK to begin on August 18, 2023

Aug 14, 2023 08:00 am ET

Ra Medical Systems Announces Allowance of New Closure Device Patent

First patent out of six applications on file for LockeT product

Aug 07, 2023 08:00 am ET

Ra Medical Systems Announces Milestone Achievement for Electrophysiology Division

Catheter Precision's VIVO System Has Been Utilized in over 1,000 Procedures

Jul 31, 2023 08:00 am ET

Ra Medical Systems Announces Proposed Name and Ticker Symbol Changes

Name change to Catheter Precision, Inc. expected to become effective on August 17, 2023, with trading under new ticker symbol VTAK expected to begin on August 18, 2023

Jul 24, 2023 08:00 am ET

Ra Medical System’s Electrophysiology Division Has Increased Demand for its Non-invasive Mapping System

New Hospitals Approve Use of VIVO and Existing Customers Increase Utilization

Jul 06, 2023 08:00 am ET

RMED's LockeT Device Utilized in Structural Heart Procedures

Provides Evidence of Efficacy in Large Diameter Sheath Procedures, Expanding Use Beyond Electrophysiology Market

Jul 03, 2023 08:00 am ET

RMED’s Electrophysiology Division Expands International Distribution

Prepares for the CE Mark and International Launch of LockeT in Third Quarter 2023

Jun 28, 2023 08:00 am ET

RMED's Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023

FORT MILL, SC / ACCESSWIRE / June 28, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced that its Catheter Precision subsidiary has submitted to its European Notified Body the data necessary for determination of CE marking on its LockeT product. Recently the company concluded the final step of three-year shelf-life sterility testing which clears the pathway for achievement of the CE Mark.

Jun 12, 2023 08:00 am ET

Ra Medical’s Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO System

FORT MILL, SC / ACCESSWIRE / June 12, 2023 / Ra Medical Systems, Inc. (RMED:NYSE/American) announced today that its wholly owned subsidiary, Catheter Precision, Inc., has had its first customer, Heart Hospital of New Mexico at Lovelace Medical Center, complete 100 ventricular ablation procedures with the assistance of VIVO, a non-invasive 3D imaging system that identifies the earliest electrical activation of a ventricular arrhythmia.

Jun 02, 2023 06:35 pm ET

Ra Medical Systems Announces First Quarter Results

FORT MILL, SC / ACCESSWIRE / June 2, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced financial and company highlights for the first quarter ended March 31,2023. Among the quarter highlights are the following:

May 30, 2023 04:15 pm ET

Ra Medical Systems Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q

FORT MILL, SC / ACCESSWIRE / May 30, 2023 / Ra Medical Systems, Inc. (the "Company") (NYSE American:RMED) announced today that on May 23, 2023, the Company received a notice from NYSE Regulation stating that the Company is not in compliance with the continued listing standards of the NYSE American (the "Exchange") under the timely filing criteria set forth in Section 1007 of the NYSE American Company Guide (the "Company Guide"). The non-compliance results from the Company's previously disclosed failure to timely file its Quarterly Report on Form 1

May 22, 2023 04:30 pm ET

Ra Medical Systems Announces Delayed 10-Q Filing

FORT MILL, SC / ACCESSWIRE / May 22, 2023 / Ra Medical Systems, Inc. (RMED:NYSE/American) announced today that it will not file its Quarterly Report for the quarter ended March 31, 2023 within the filing deadline established by the Securities and Exchange Commission and will be a late filer with respect to such report.

May 16, 2023 08:00 am ET

Ra Medical Systems Provides First Corporate Update Since Merger

Sales and Clinical Field Force Onboarded and Fully Trained

May 09, 2023 07:00 am ET

Catheter Precision Announces Enrollment of 125 Subjects in the VIVO EU Registry

FORT MILL, SC / ACCESSWIRE / May 9, 2023 / Ra Medical Systems announced that its subsidiary, Catheter Precision, has enrolled 125 subjects into its European observational registry. The study will continue to enroll additional subjects and expects enrollment to be completed by June 30, 2023. After enrollment, subjects will continue to be seen for follow-up for 12 months post ablation procedure. Complete data results are anticipated to be available in Q4 2024 with interim results available before then.

Apr 18, 2023 04:10 pm ET

CORRECTION: Ra Medical Electrophysiology Division Participates in EHRA Congress

This press release corrects and replaces one issued previously correcting the title of David Jenkins.

Apr 18, 2023 08:00 am ET

Ra Medical Announces Resignation of CEO

Board Committee Seeking Replacement

Apr 17, 2023 08:00 am ET

Ra Medical Electrophysiology Division is Participating in EHRA Congress

FORT MILL, SC / ACCESSWIRE / April 17, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced today that its wholly owned subsidiary, Catheter Precision, Inc., participates in the European Heart Rhythm Association (EHRA). EHRA will take place in Barcelona, Spain from April 16-18. As a branch of the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA) is the leading network of European Cardiac Rhythm Management. The EHRA is a strong association with more than 4,100 members around the globe, including physicians, arrhythmologists, young elec

Mar 30, 2023 07:30 am ET

Ra Medical Systems Announces Change in Chief Financial Officer Position Previous Acting CFO Position Replaced with Permanent Appointment

FORT MILL, SC / ACCESSWIRE / March 30, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced the appointment of Steven Passey as Chief Financial Officer effective April 1, 2023, replacing Brian Conn, who has been serving as Acting Chief Financial Officer.

Mar 27, 2023 07:30 am ET

Ra Medical Systems Announces Closing of $8 Million Private Placement

FT. MILL, SC / ACCESSWIRE / March 27, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) today announces that it has closed its previously announced private placement, which generated $8 million in gross proceeds.

Mar 21, 2023 04:05 pm ET

Ra Medical Systems Announces Results of Special Meeting of Stockholders

Intends to close on $8 million financing

Mar 20, 2023 08:00 am ET

Ra Medical Systems Announces Expansion to New European Territory

FORT MILL, SC / ACCESSWIRE / March 20, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced today that its wholly owned subsidiary, Catheter Precision, Inc., has registered its leading product, VIVO, in Switzerland and has completed first cases in the new territory.

Mar 17, 2023 08:00 am ET

Ra Medical Systems Announce Issuance of Additional International Patent

FORT MILL, SC / ACCESSWIRE / March 17, 2023 / Ra Medical Systems, Inc. (RMED:NYSE/American) today announced that its wholly owned subsidiary, Catheter Precision, Inc., has received notification of an additional issuance of a new international patent. The patent is part of the evolving number of patents surrounding the company's VIVO technology. The patent, entitled "Methods of Cardiac Mapping and Model Merging" has been issued in the country of Japan.

Mar 09, 2023 02:30 pm ET

Ra Medical Systems Announces Granting of New US Patent

FORT MILL, SC / ACCESSWIRE / March 9, 2022 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced that it has been notified of a new patent granted by the USPTO covering technology utilized in its VIVO product. The patent, number D980,420 S, entitled "Kit of Positioning Patches", was issued on March 7, 2023. The patent covers technology used in the disposable components of the VIVO product.

Mar 08, 2023 08:00 am ET

Ra Med Electrophysiology Division Announces New Publication of Clinical Data

New Study Confirms Advantages of Using VIVO for Pre-Procedure Ventricular Ablation Planning

Mar 06, 2023 08:00 am ET

Ra Medical's Electrophysiology Division Announces First Use of New Product

Catheter Precision's LockeT Successfully Used in Series of Patients

Feb 14, 2023 09:20 am ET

Ra Med Division Announces Product Launch of LockeT Device

Initial Shipments to Begin This Week

Feb 10, 2023 09:20 am ET

Ra Medical Systems Announces Date of Special Shareholder Meeting

FORT MILL, SC / ACCESSWIRE / February 10, 2023 / Ra Medical Systems (NYSE American:RMED) today announced the date of March 21, 2023 as the date of its special shareholder meeting. Shareholders of record as of February 3, 2023 are entitled to vote at the meeting.

Feb 01, 2023 09:20 am ET

Ra Medical Systems Adds Additional Clinical and Sales Representatives

Catheter Precision Expands its VIVO™ Product into New Territories in the US

Jan 23, 2023 06:50 am ET

Ra Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association Congress

Ra Medical Systems, Inc. (NYSE American: RMED) (Ra Medical), a medical device and technology company focused on cardiac electrophysiology, announces that four abstracts with clinical data supporting its VIVO technology have been accepted for presentation at the European Heart Rhythm Association Congress (EHRA 2023) being held April 16-18, 2023 in Barcelona. VIVO, developed by Ra Medical’s wholly owned subsidiary Catheter Precision, is a proprietary AI system used to non-invasively identify the origin of ventricular arrhythmias prior to an ablation procedure.

Jan 17, 2023 06:50 am ET

Ra Medical Systems Realigns Its Board of Directors

Ra Medical Systems (NYSE American: RMED) announces a realignment of its board of directors in conjunction with the recently announced merger with Catheter Precision, Inc. David Jenkins has joined the board as Executive Chairman and James Caruso has been named director. Martin Colombatto, Will McGuire a

Jan 09, 2023 07:30 pm ET

Ra Medical Systems Completes Merger with Catheter Precision

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces the completion of its previously announced stock-for-stock merger transaction with Catheter Precision, Inc., a company focused on the cardiac electrophysiology market. Medtech veteran and Catheter Precision CEO and founder David Jenkins has joined Ra Medical’s Board of Directors as Executive Chairman. Mr. Jenkins was instrumental in operating several medical device startups, including Transneuronix, Inc., which was acquired by Medtronic plc (NYSE: MDT) in July 2005, and EP MedSystems, Inc., which was acqui

Dec 14, 2022 04:33 pm ET

Ra Medical Systems Regains Compliance with NYSE American Continued Listing Standards

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces that it has received notification from the NYSE American LLC (“NYSE American”) that the Company has regained compliance with the NYSE American’s continued listing standard. Specifically, the Company has resolved the continued listing deficiency with respect to its low selling price as described in Section 1003(f)(v) of the NYSE American Company Guide.

Dec 02, 2022 07:31 am ET

Thinking about buying stock in Anavex Life Sciences, RA Medical Systems, Samsara, UiPath, or Smartsheet?

NEW YORK, Dec. 2, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVXL, RMED, IOT, PATH, and SMAR.

Dec 01, 2022 07:35 am ET

Thinking about buying stock in Altimmune, Lordstown Motors, Sonim Technologies, Nutanix, or RA Medical?

NEW YORK, Dec. 1, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ALT, RIDE, SONM, NTNX, and RMED.

Dec 01, 2022 06:50 am ET

Catheter Precision’s VIVO™ System Used in More Than 800 Procedures in Leading U.S. and European Hospitals

Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces that more than 800 procedures have been performed in a number of leading U.S. and European hospitals utilizing the VIVO System that enables physicians to noninvasively identify an area of ventricular arrhythmia onset.

Nov 29, 2022 06:50 am ET

Catheter Precision’s VIVO™ Systems Used in More Than 20 Procedures at NYU Langone Hospital

Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces the completion of more than 20 procedures at NYU Langone Hospital utilizing the VIVO System that enables physicians to identify the origin of arrhythmias pre-procedure. On September 12, 2022 privately held Catheter Pre

Nov 14, 2022 05:42 pm ET

Ra Medical Systems Reports Third Quarter 2022 Financial Results

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) reports financial results for the three and nine months ended September 30, 2022 and provides a business update.

Oct 28, 2022 11:25 am ET

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, RCKT, RMED, RCOR

NEW YORK, Oct. 28, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Oct 27, 2022 06:41 pm ET

SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations

NEW YORK, Oct. 27, 2022 /PRNewswire/ --

Oct 20, 2022 04:05 pm ET

Catheter Precision Expands U.S. Customer Base for VIVO™ for Non-invasive Arrythmia Location Detection Before Ventricular Ablation Procedures

Catheter Precision, Inc. (“Catheter Precision”), a medical device company focused on cardiac electrophysiology, announces receipt of three commercial orders in the past 60 days as usage of the device continues to increase in the U.S. On September 12, 2022 privately held Catheter Precision announced a

Oct 18, 2022 11:35 am ET

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNBE, CYBE, EQ, MNRL, RMED

NEW YORK, Oct. 18, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Oct 18, 2022 08:30 am ET

Thinking about buying stock in RA Medical, Aveo Pharmaceuticals, FuboTV, Canoo, or 89bio?

NEW YORK, Oct. 18, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RMED, AVEO, FUBO, GOEV, and ETNB.

Oct 17, 2022 04:05 pm ET

Ra Medical Systems Raises $7.6 Million Through Completed At-The-Market Facility

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces the completion of its at-the-market (ATM) facility, raising gross proceeds of $7.6 million. The Company sold 1,072,246 shares of common stock at a weighted average price of $7.09 per share, as adjusted for a reverse split effected September 30, 2022, resulting in net proceeds of approximately $7.4 million after deducting sales commissions.

Oct 17, 2022 08:00 am ET

SHAREHOLDER ALERT: Weiss Law Reminds RMED, CYBE, LTRY, and MNRL Shareholders About Its Ongoing Investigations

NEW YORK, Oct. 17, 2022 /PRNewswire/ --

Oct 07, 2022 10:47 am ET

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VMW, IRBT, RMED

NEW YORK, Oct. 7, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Oct 06, 2022 08:32 am ET

Thinking about buying stock in Pineapple Energy, iMedia Brands, Revelation Biosciences, RA Medical Systems, or First Wave BioPharma?

NEW YORK, Oct. 6, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PEGY, IMBI, REVB, RMED, and FWBI.

Oct 05, 2022 10:00 pm ET

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger - IRBT, CYBE, TRQ, HIL, RMED

NEW YORK, Oct. 5, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:

Oct 04, 2022 08:00 am ET

Catheter Precision Files a Method-of-Use U.S. Patent Application for its VIVO™ Technology

Catheter Precision, Inc. (“Catheter Precision”), a medical device company focused on cardiac electrophysiology, announces the filing of a new U.S. patent application for its VIVO™ (View Into Ventricular Onset) technology, as it continues its focus on patent protection for VIVO. On September 12, 2022 privately held Catheter Precision announced a

Oct 03, 2022 09:35 pm ET

SHAREHOLDER ALERT: Weiss Law Reminds BTRS, RMED, CYBE, and LTRY Shareholders About Its Ongoing Investigations

NEW YORK, Oct. 3, 2022 /PRNewswire/ --

Oct 02, 2022 09:28 am ET

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Acquisition – SGFY, TRQ, HIL, RMED

Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and...

Sep 30, 2022 09:57 am ET

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IRBT, MNRL, SBET, RMED

NEW YORK, Sept. 30, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Sep 29, 2022 08:00 am ET

Catheter Precision’s VIVO™ Technology to be Featured in Three Presentations at the Global Society of Cardiac Robotic Navigation Annual Meeting

Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces that its lead product, VIVO™ (View Into Ventricular Onset), will be featured in presentations by three physicians working in the field of cardiac electrophysiology at the Sixth Annual Society of Cardiac Robotic Navigat

Sep 27, 2022 08:00 am ET

Catheter Precision Names Fatih Ayoglu as Business Development Manager—EMEA

Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces the appointment of Fatih Ayoglu to the newly created position of Business Development Manager—EMEA. Mr. Ayoglu will oversee clinical and sales development of Catheter Precision products in Europe, the Middle East and A

Sep 26, 2022 10:08 am ET

EQUITY ALERT: The M&A Class Action Firm Continues to Investigate Merger – SGFY, TRQ, STOR, RMED

Sep 24, 2022 02:45 pm ET

INVESTOR ALERT: The M&A Class Action Firm Announces Launches Merger Inquiry - SGFY, TRQ, STOR, RMED

NEW YORK, Sept. 24, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:

Sep 23, 2022 06:45 am ET

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TALO, CYBE, TMX, RMED

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Talos Energy Inc. (NYSE: TALO)’s...

Sep 22, 2022 06:29 pm ET

SHAREHOLDER ALERT: Weiss Law Reminds RMED, CYBE, LTRY, and TMX Shareholders About Its Ongoing Investigations

NEW YORK, Sept. 22, 2022 /PRNewswire/ --

Sep 22, 2022 11:25 am ET

Thinking about buying stock in Ecmoho, Xpeng, Li Auto, Transocean, or RA Medical Systems?

NEW YORK, Sept. 22, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MOHO, XPEV, LI, RIG, and RMED.

Sep 22, 2022 09:35 am ET

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBET, RMED, OCSL, SESN

NEW YORK, Sept. 22, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Sep 21, 2022 08:31 am ET

Thinking about buying stock in RA Medical Systems, FREYR Battery, PBF Energy, Coty, or Syros Pharmaceuticals?

NEW YORK, Sept. 21, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RMED, FREY, PBF, COTY, and SYRS.

Sep 20, 2022 04:48 pm ET

Ra Medical Systems Announces Results of its Special Meeting of Stockholders and a 1-for-50 Reverse Stock Split

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces that at its virtual Special Meeting of Stockholders held today, the Company’s stockholders approved all three proposals on the proxy filed with the Securities and Exchange Commission on August 29,

Sep 19, 2022 04:07 pm ET

The M&A Class Action Firm Announces an Investigation of the Merger – SGFY, TRQ, STOR, RMED

Sep 19, 2022 03:28 pm ET

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Gemini Therapeutics, Inc. (Nasdaq - GMTX), CyberOptics Corporation (Nasdaq – CYBE), STORE Capital Corporation

Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no...

Sep 16, 2022 05:25 pm ET

SHAREHOLDER ALERT: Weiss Law Reminds RMED, CYBE, LTRY, and MSTR Shareholders About Its Ongoing Investigations

NEW YORK, Sept. 16, 2022 /PRNewswire/ --

Sep 15, 2022 10:55 am ET

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) STORE Capital Corporation (NYSE - STOR), Ra Medical Systems, Inc. (NYSE American - RMED), Brigham Minerals, In

Sep 14, 2022 01:13 pm ET

Shareholder Alert: Ademi LLP investigates whether Ra Medical Systems, Inc.'s transaction with Catheter Precision is fair to shareholders

MILWAUKEE, Sept. 14, 2022 /PRNewswire/ -- Ademi LLP is investigating Ra Medical (NYSE American: RMED) for possible breaches of fiduciary duty and other violations of law in its transaction with Catheter Precision.

Sep 14, 2022 10:05 am ET

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates GMTX, RMED, LOTZ

NEW YORK, Sept. 14, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Sep 13, 2022 05:04 pm ET

SHAREHOLDER ALERT: Weiss Law Investigates Ra Medical Systems, Inc.

NEW YORK, Sept. 13, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Ra Medical Systems, Inc. ("Ra Medical" or the "Company") (NYSE: RMED) in connection with the proposed merger of the Company with Catheter Precision, Inc. ("Catheter Precision"). The Merger is structured as a stock for stock reverse merger whereby all of Catheter Precision's outstanding convertible promissory notes and equity interests are to be exchanged for shares of Ra Medical common stock and Catheter Precision options assumed by

Sep 12, 2022 09:46 pm ET

RA MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Ra Medical Systems, Inc. - RMED

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Ra Medical Systems, Inc. (NYSE: RMED) (“the Company”) with Catheter Precision, Inc. pursuant to which Ra Medical shareholders will own approximately 20% of the combined company, on a fully diluted basis calculated using the treasury stock method, subject to certain adjustments. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

Sep 12, 2022 04:55 pm ET

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ECOM, SGFY, RMED

Sep 12, 2022 03:27 pm ET

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ra Medical Systems, Inc. (NYSE American - RMED), Brigham Minerals, Inc. (NYSE - MNRL), Signify Health, Inc. (NY

Sep 12, 2022 09:05 am ET

RMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Ra Medical Systems, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Ra Medical Systems, Inc. (NYSE: RMED) and Catheter Precision, Inc. is fair to Ra Medical shareholders.

Sep 12, 2022 08:30 am ET

Thinking about buying stock in Ventyx Biosciences, Aterian, Aditxt, RA Medical Systems, or Spectrum Pharmaceuticals?

NEW YORK, Sept. 12, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VTYX, ATER, ADTX, RMED, and SPPI.

Sep 12, 2022 05:50 am ET

Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces it has entered into an Agreement and Plan of Merger (the “Definitive Merger Agreement”) with privately held Catheter Precision, Inc. (“Catheter Precision”), a medical device and technology company focused in the field of cardiac electrophysiol

Sep 02, 2022 04:05 pm ET

Ra Medical Systems Receives NYSE American Notice

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces that on August 31, 2022, it received a notice (the “Notice”) that the NYSE American LLC has determined the Company’s securities have been selling at a low price per share for a substantial period of time. Pursuant to Section 1003(f)(v) of the NYSE American Company Guide, the Company’s continued listing is predicated on it effecting a reverse stock split of its common stock or otherwise demonstrating sustained price improvement within a reasonable period of time, which the NYSE American has determined to be

Aug 15, 2022 04:21 pm ET

Ra Medical Systems Reports Second Quarter 2022 Financial Results

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) reports financial results for the three and six months ended June 30, 2022 and provides a business update.

Aug 01, 2022 06:50 am ET

Ra Medical Systems Provides Update on its Annual Filings

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces that its audited consolidated financial statements for the fiscal year ended December 31, 2021 included in the Company’s Form 10-K filed with the Securities and Exchange Commission (SEC) on March 24, 2022 and Amended Form 10-K/A filed with the SEC on July 7, 2022 contained an audit report from its independent registered public accounting firm which included a going concern emphasis of matter paragraph. Release of this information is required by Section 610(b) of the NYSE American Company Guide. It does not

Jul 22, 2022 08:30 am ET

Ra Medical Systems Enters Into Agreements to Raise $6.2 Million Through Previously Issued Warrants and Plans Strategic Merger with Catheter Precision Inc.

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces a reduction in the exercise price of all existing warrants that were issued in the February 2022 public offering, consisting of Series A Warrants and Series B Warrants, from $0.50 per share to $0.28 per share, and entry into a non-binding term sheet to merge with privately held Catheter Precision Inc. (“Catheter Precision”).

Jul 18, 2022 06:50 am ET

Ra Medical Systems Appoints Brian D. Conn Interim Chief Financial Officer

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the appointment of Brian D. Conn as interim Chief Financial Officer, effective immediately. Mr. Conn will serve as the Company’s Principal Financial Officer and Principal Accounting Officer.

May 16, 2022 04:05 pm ET

Ra Medical Systems Reports First Quarter 2022 Financial Results

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or “the Company”), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months ended March 31, 2022 and provides a business update.

May 09, 2022 06:50 am ET

Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022

Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday, May 16. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provi

Apr 05, 2022 08:30 am ET

Ra Medical Systems Granted U.S. Patent for Laser Ablation Catheters with Expanded Ablation Area

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the United States Patent and Trademark Office has granted the company a patent for liquid-filled laser ablation catheters with expanded distal optical windows. U.S. patent 11,284,941 (the ’941 patent), titled Laser Ablation Catheters Having Expanded Distal Tip Windows for Efficient Tissue Ablation, describes a catheter with an increased ablation surface area at the distal catheter tip. This is the 11th U.S. paten

Mar 28, 2022 08:30 am ET

Ra Medical Systems Achieves Milestone of 100 Subjects Enrolled in its Pivotal Atherectomy Clinical Study

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the achievement of a milestone with the enrollment of 100 subjects in its pivotal clinical study to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treatment of peripheral arterial disease (PAD). This pivotal atherectomy study is cleared to enroll up to 125 subjects.

Mar 23, 2022 04:05 pm ET

Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months and full year ended December 31, 2021 and provides a business update.

Mar 15, 2022 04:05 pm ET

Ra Medical Systems to Report 2021 Fourth Quarter and Full Year Financial Results on March 23, 2022

Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report 2021 fourth quarter and full year financial results after market close on Wednesday, March 23. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide

Feb 28, 2022 08:30 am ET

Ra Medical Systems Files 510(k) Application for the DABRA Catheter with Braided Overjacket and Six-Month Shelf Life

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the filing of a 510(k) application with the U.S. Food and Drug Administration (FDA) for the company’s next-generation DABRA catheter with a braided overjacket and a six-month shelf life as a device for crossing chronic total occlusions in patients with symptomatic infrainguinal lower extremity vascular disease and with an intended use for ablating a channel in occlusive peripheral vascular disease. The overjacket design increases

Feb 18, 2022 06:50 am ET

Ra Medical Systems Provides an Update on Enrollment in Its Pivotal Atherectomy Clinical Trial

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on developing its excimer laser system to treat vascular diseases, announces enrollment has reached 95 subjects in its pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treatment of peripheral arterial disease (PAD). The company also announces approval from the U.S. Food and Drug Administration (FDA) to increase subject enrollment from 100 subjects to 125 subjects.

Feb 10, 2022 06:50 am ET

Ra Medical Systems Granted U.S. Patent for a Support Catheter for use Supporting a Liquid Core Ablation Catheter

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces that on February 8, 2022, the United States Patent and Trademark Office granted the company a patent for a support catheter used with a small flexible liquid core catheter for laser ablation of arterial plaque blockages to restore blood flow. This is the 10th U.S. patent issued to Ra Medical and further strengthens protection of the company’s novel liquid core ablation catheters.

Feb 08, 2022 04:05 pm ET

Ra Medical Systems, Inc. Announces Closing of $12.1 Million Underwritten Public Offering

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, today announced the closing of an underwritten public offering of units and pre-funded units for aggregate gross proceeds of approximately $12.1 million, prior to deducting underwriting discounts and commissions and offering expenses.

Feb 04, 2022 09:50 am ET

Thinking about buying stock in RA Medical Systems, Kaival Brands Innovations, Transocean, Deutsche Bank, or BP?

NEW YORK, Feb. 4, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RMED, KAVL, RIG, DB, and BP.

Feb 04, 2022 08:30 am ET

Ra Medical Systems, Inc. Announces Pricing of $12.0 Million Underwritten Public Offering

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, today announced the pricing of an underwritten public offering of units for gross proceeds of approximately $12.0 million prior to deducting underwriting discounts and commissions and offering expenses.

Jan 20, 2022 06:50 am ET

Ra Medical Systems CEO Issues Letter to Stockholders

Ra Medical Systems, Inc. (NYSE American: RMED) announces that Chief Executive Officer Will McGuire has issued the following Letter to Stockholders:

Nov 15, 2021 04:05 pm ET

Ra Medical Systems Reports 2021 Third Quarter Financial Results

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three and nine months ended September 30, 2021 and provides a business update.

Nov 08, 2021 06:50 am ET

Ra Medical Systems to Report Third Quarter 2021 Financial Results on November 15, 2021

Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report third quarter 2021 financial results after market close on Monday, November 15. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company upda

Sep 27, 2021 09:31 am ET

Thinking about buying stock in Syndax Pharmaceuticals, Tellurian, RA Medical Systems, AST SpaceMobile, or Aditxt?

NEW YORK, Sept. 27, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDX, TELL, RMED, ASTS, and ADTX.

Sep 07, 2021 04:05 pm ET

Ra Medical Systems to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular diseases, announces that management will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference being held September 13-15, 2021. A webcast of the presentation will be

Aug 16, 2021 04:05 pm ET

Ra Medical Systems Reports 2021 Second Quarter Financial Results

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing its excimer laser system to treat vascular disease, reports financial results for the three and six months ended June 30, 2021 and provides a business update.

Aug 16, 2021 04:03 pm ET

Ra Medical Systems Announces Sale of Pharos Dermatology Business

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing its excimer laser system to treat vascular disease, announces the sale of its Pharos dermatology business to STRATA Skin Sciences (Nasdaq: SSKN) for $3.7 million in cash. The Pharos excimer laser is FDA-cleared for the treatment of psoriasis, vitil

Aug 09, 2021 06:50 am ET

Ra Medical Systems to Report Second Quarter 2021 Financial Results on August 16, 2021

Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report second quarter 2021 financial results after market close on Monday, August 16, 2021. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company

Aug 02, 2021 09:31 am ET

Thinking about buying stock in Exicure, Orbital Energy, Vaxart, Li Auto, or RA Medical?

NEW YORK, Aug. 2, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XCUR, OEG, VXRT, LI, and RMED.

Jun 29, 2021 09:31 am ET

Thinking about buying stock in Amesite, SoFi Technologies, Phunware, Eiger Biopharmaceuticals, or RA Medical Systems?

NEW YORK, June 29, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMST, SOFI, PHUN, EIGR, and RMED.

Jun 29, 2021 06:50 am ET

Ra Medical Systems Announces Progress with Guidewire-Compatible Catheter Design and Provides Update on Atherectomy Trial Enrollment

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces progress with finalizing the next-generation guidewire-compatible DABRA catheter design following a recent two-day, hands-on workshop with interventionalists who eval

Jun 16, 2021 09:31 am ET

Thinking about buying stock in Aprea Therapeutics, RA Medical Systems, AMC Entertainment, Torchlight Energy Resources, or Appharvest?

NEW YORK, June 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APRE, RMED, AMC, TRCH, and APPH.

Jun 14, 2021 08:00 am ET

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Ra Medical Systems, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

NEW YORK, June 14, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Ra Medical Systems, Inc. (NYSE American: RMED).

May 11, 2021 04:05 pm ET

Ra Medical Systems Reports 2021 First Quarter Financial Results

May 10, 2021 06:50 am ET

Ra Medical Systems to Report First Quarter 2021 Financial Results on May 11, 2021

Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report first quarter 2021 financial results after market close on Tuesday, May 11, 2021. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company upd

Apr 20, 2021 06:05 am ET

Ra Medical Systems Provides Enrollment Update for its Pivotal Atherectomy Clinical Trial

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces an increase in enrollment in its pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treat

Apr 19, 2021 05:02 pm ET

Ra Medical Systems to Report First Quarter 2021 Financial Results on May 11, 2021

Mar 16, 2021 04:05 pm ET

Ra Medical Systems Reports 2020 Fourth Quarter and Full Year Financial Results

Mar 11, 2021 06:50 am ET

Ra Medical Systems to Participate in Upcoming Virtual Investment Conferences

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will participate in two upcoming virtual investment conferences:

Mar 09, 2021 06:50 am ET

Ra Medical Systems to Report 2020 Fourth Quarter and Full Year Financial Results on March 16, 2021

Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report 2020 fourth quarter and full year financial results and provide a business update after market close on Tuesday, March 16, 2021. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss finan

Mar 02, 2021 06:50 am ET

Ra Medical Systems to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will present a company overview and hold virtual meetings with investors at the H.C. Wainwright Global Life Sciences Virtual Conference being held March 9-10, 2021.

Feb 04, 2021 04:05 pm ET

Ra Medical Systems Appoints Susanne L. Meline to its Board of Directors

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces the appointment of Susanne L. Meline to its Board of Directors, effective January 31, 2021. Her appointment expands Board membership to seven.

Jan 27, 2021 06:50 am ET

Ra Medical Systems Reports Progress with Extending DABRA Catheter Shelf Life, Completes Quality Improvement Plan

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, reports progress with extending the shelf life of its more robust, next generation DABRA catheter, featuring a braided overjacket to improve deliverability when navigating tortuous anatomy. The Company also announces completion of all 116 items identified in a quality improvement plan that stemmed from an internal audit in late 2019, with enhancements to standard operating procedures, preventive maintenance, equipment status,

Jan 06, 2021 06:50 am ET

Ra Medical Systems to Present at H.C. Wainwright Virtual BioConnect Conference

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will present at the H.C. Wainwright Virtual BioConnect Conference.

Jan 04, 2021 06:50 am ET

Ra Medical Systems Announces Settlement Resolving Previously Announced United States Department of Justice and State Investigations

Ra Medical Systems, Inc. (NYSE American: RMED) today announced it has entered into a settlement agreement that resolves civil False Claims Act claims asserted by the United States Department of Justice in an investigation previously disclosed by the Company. Ra Medical Systems has settled these matters without admitting liability or wrongdoing. The allegations resolved as part of the settlement agreement reached with the U.S. Attorney’s Office for the Eastern District of Michigan pertain to the Company’s marketing of the DABRA laser system and DABRA-related remuneration paid to certain physici

Dec 17, 2020 10:41 am ET

Ra Medical Systems Announces Transfer of Listing to NYSE American

Ra Medical Systems, Inc. (NYSE: RMED) , a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that its common stock has been approved for listing on the NYSE American, and the listing will be transferred by the New York Stock Exchange (NYSE).

Dec 11, 2020 06:50 am ET

Ra Medical Systems Announces the Availability of its Webcast Event Discussing the Role of Excimer Lasers in the Treatment of Psoriasis During the Pandemic

Ra Medical Systems, Inc. (NYSE: RMED) announces the availability of its webcast event, The Inimitable Role of Excimer Lasers During the COVID-19 Pandemic, discussing the use of excimer lasers such as the Pharos excimer laser system for the treatment of psoriasis during the pandemic. The event, featuring Theodore J. Daly, MD, FAAD, FSPD, FASD, Director of Garden City Dermatology, is available

Dec 07, 2020 11:00 am ET

The Law Offices of Frank R. Cruz Continues Its Investigation of Ra Medical Systems, Inc. (RMED) on Behalf of Investors

LOS ANGELES, Dec. 7, 2020 /PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of potential claims against the board of directors of Ra Medical Systems, Inc. ("Ra Medical" or the "Company") (NYSE: RMED) concerning whether the board breached its fiduciary duties to shareholders.

Dec 01, 2020 06:50 am ET

Reminder: Ra Medical Systems to Host Webcast Discussing the Role of Excimer Lasers in the Treatment of Psoriasis during the Pandemic

Ra Medical Systems, Inc. (NYSE: RMED) is hosting a webcast, The Inimitable Role of Excimer Lasers During the COVID-19 Pandemic, featuring Theodore J. Daly, MD, FAAD, FSPD, FASD, Director of Garden City Dermatology, discussing the use of excimer lasers such as the Pharos excimer laser system for the treatment of psoriasis during the pandemic.

Nov 24, 2020 06:50 am ET

Ra Medical Systems to Participate in the Piper Sandler Virtual Health Care Conference

Nov 18, 2020 06:50 am ET

Ra Medical Systems to Feature the Pharos Optimized Excimer Laser at the Virtual New Frontiers in Cosmetic Medicine & Medical Dermatology Symposium

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces it will feature the Pharos excimer laser at the New Frontiers in Cosmetic Medicine & Medical Dermatology Symposium 2020 Virtual Meeting being held November 21, 2020.

Nov 16, 2020 04:05 pm ET

Ra Medical Systems Announces 1-for-25 Reverse Stock Split

Ra Medical Systems, Inc. (NYSE: RMED) announced today that its Board of Directors has approved a 1-for-25 reverse stock split of the Company’s common stock, which will be effective at 5:00 p.m. Eastern Time on Monday, November 16, 2020. The Company’s stockholders previously approved the reverse stock split at the Annual Meeting of Stockholders on November 10, 2020. The Company’s shares will begin trading on a split-adjusted basis on the New York Stock Exchange commencing upon market open on November 17, 2020.

Nov 13, 2020 06:50 am ET

Ra Medical Systems to Participate in A.G.P.’s Virtual Healthcare Symposium

Ra Medical Systems, Inc. (NYSE: RMED) , a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will participate in A.G.P.’s Virtual Healthcare Symposium. This event, which features one-on-one meetings, is being held Thursday, November 19, 2020.

Nov 12, 2020 04:05 pm ET

Ra Medical Systems Reports 2020 Third Quarter Financial Results

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, reports financial results for the three and nine months ended September 30, 2020 and provides a business update.

Nov 11, 2020 06:50 am ET

Ra Medical Systems to Host Webcast Discussing the Role of Excimer Lasers in the Treatment of Psoriasis during the Pandemic

Nov 09, 2020 06:50 am ET

Ra Medical Systems Hosts Summit with Vascular Physicians to Monitor Progress on Next-Generation DABRA Catheter Design

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces a one-day DABRA Summit, during which participants will have the opportunity to provide input on the design features and enhancements for the Company’s next-generation DABRA catheters. Principal investigators and study coordinators from Ra Medical’s DABRA pivotal atherectomy clinical trial will also meet to share with one another insights on best practices.

Nov 05, 2020 06:50 am ET

Ra Medical Systems to Report Third Quarter 2020 Financial Results on November 12, 2020

Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report third quarter 2020 financial results and provide a business update after market close on Thursday, November 12, 2020. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial result

Oct 23, 2020 12:30 pm ET

The Law Offices of Frank R. Cruz Continues Its Investigation of Ra Medical Systems, Inc. (RMED) on Behalf of Investors

The Law Offices of Frank R. Cruz continues its investigation of potential claims against the board of directors of Ra Medical Systems, Inc. (“Ra Medical” or the “Company”) (NYSE:

Oct 14, 2020 04:05 pm ET

Ra Medical Systems Announces 10 Subjects Have Been Enrolled in its DABRA Pivotal Atherectomy Clinical Trial

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces enrollment of the 10th subject in its pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treatment of peripheral arterial disease (PAD).

Sep 09, 2020 06:50 am ET

Ra Medical Systems to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 16

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will present at the H.C. Wainwright 22nd Annual Global Investment Conference on Wednesday, September 16, 2020 at 1:00 p.m. Eastern time (10:00 a.m. Pacific time). A live webcast of the presentation will be available on the Ra Medical website at

Aug 31, 2020 05:00 pm ET

LD Micro - 360 Companies Set to Present - this Week

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

Aug 11, 2020 04:05 pm ET

Ra Medical Systems Reports 2020 Second Quarter Financial Results

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, reports financial results for the three and six months ended June 30, 2020 and provides a business update.

Aug 05, 2020 09:00 am ET

LD Micro Announces Preliminary List of Presenters for the LD-500

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

Aug 04, 2020 06:50 am ET

Ra Medical Systems to Report Second Quarter 2020 Financial Results on August 11, 2020

Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report second quarter 2020 financial results and provide a business update after market close on Tuesday, August 11, 2020. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results

Aug 03, 2020 04:05 pm ET

Ra Medical Systems Announces Closing of $12.0 Million Upsized Public Offering

Ra Medical Systems, Inc. (“Ra Medical”) (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases, today announced that it has closed the previously announced public offering of an aggregate of 34,285,714 shares of common stock (or common stock equivalents), together with accompanying warrants to purchase up to an aggregate of 34,285,714 shares of common stock, at a public offering price of $0.35 per share and accompanying warrant. Each share of commo

Jul 30, 2020 11:46 am ET

Ra Medical Systems Announces Pricing of $12.0 Million Upsized Public Offering

Ra Medical Systems, Inc. (“Ra Medical”) (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases, today announced that it has priced a public offering of an aggregate of 34,285,714 shares of common stock (or common stock equivalents), together with accompanying warrants to purchase up to an aggregate of 34,285,714 shares of common stock, at a public offering price of $0.35 per share and accompanying warrant. Each share of common stock (or common stoc

Jun 24, 2020 01:23 pm ET

The Law Offices of Frank R. Cruz Announces Investigation of Ra Medical Systems, Inc. (RMED)

The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Ra Medical Systems, Inc. (“Ra Medical” or the “Company”) (NYSE:

Jun 19, 2020 10:50 pm ET

RA MEDICAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ra Medical Systems, Inc. - RMED

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Ra Medical Systems, Inc. (NYSE: RMED).

May 22, 2020 10:50 pm ET

RA MEDICAL INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ra Medical Systems, Inc. - RMED

NEW ORLEANS, May 22, 2020 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Ra Medical Systems, Inc. (NYSE: RMED).

May 22, 2020 03:23 pm ET

Ra Medical Systems Announces Closing of $10.0 Million Public Offering

Ra Medical Systems, Inc. (“Ra Medical”) (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases, today announced that it has closed the previously announced public offering of an aggregate of 22,222,222 shares of common stock (or common stock equivalents), together with accompanying warrants to purchase up to an aggregate of 22,222,222 shares of common stock, at a public offering price of $0.45 per share and accompanying warrant. Each share of commo

May 22, 2020 06:50 am ET

Ra Medical Systems Receives Continued Listing Standard Notice from the NYSE

Ra Medical Systems, Inc. (“Ra Medical”) (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases, today announced receipt of written notice from The New York Stock Exchange (the “NYSE”) indicating that Ra Medical is no longer in compliance with the NYSE’s continued listing standards as set forth in Section 802.01C of the NYSE’s Listed Company Manual, which requires listed companies to maintain an average closing share price of at least $1.00 over a c

May 20, 2020 09:16 am ET

Ra Medical Systems Announces Pricing of $10.0 Million Public Offering

Ra Medical Systems, Inc. (“Ra Medical”) (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases, today announced that it has priced a public offering of an aggregate of 22,222,222 shares of common stock (or common stock equivalents), together with accompanying warrants to purchase up to an aggregate of 22,222,222 shares of common stock, at a public offering price of $0.45 per share and accompanying warrant. Each share of common stock (or common stoc

May 13, 2020 04:05 pm ET

Ra Medical Systems Reports 2020 First Quarter Financial Results

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, reports financial results for the three months ended March 31, 2020 and provides a business update.

May 06, 2020 06:50 am ET

Ra Medical Systems to Report First Quarter 2020 Financial Results on May 13, 2020

Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report first quarter 2020 financial results and provide a business update after market close on Wednesday, May 13, 2020. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results an

May 01, 2020 10:50 pm ET

RA MEDICAL INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ra Medical Systems, Inc. - RMED

Apr 29, 2020 06:50 am ET

Ra Medical Systems Appoints Joan Stafslien to its Board of Directors

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces the appointment of Joan Stafslien to its Board of Directors, effective April 24, 2020 and expanding Board membership to seven. Ms. Stafslien brings to Ra Medical more than 25 years of legal and regulatory experience, primarily in the medical device industry, including serving as General Counsel at NuVasive, Inc. (Nasdaq: NUVA) and CareFusion Corporation.

Mar 30, 2020 04:05 pm ET

Ra Medical Systems Reports New Employment Inducement Award Under NYSE Listing Rules

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, today announced it has granted an equity inducement award to Jonathan Will McGuire, the Company’s new chief executive officer, who commenced employment with the Company on March 30, 2020. The stock option and restricted stock award were granted to Mr. McGuire under the 2020 Inducement Equity Incentive Plan (the “Plan”). The Plan was adopted by the Ra Medical Board of Directors in March 2020 in accordance with New York Stock Exchange Ru

Mar 12, 2020 04:45 pm ET

Ra Medical Systems Appoints Medtech Executive Will McGuire as CEO and Director

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces the appointment of Will McGuire as Chief Executive Officer and a member of the company’s Board of Directors, effective March 30, 2020. Andrew Jackson, who has served as Inter

Mar 10, 2020 04:05 pm ET

Ra Medical Systems Reports 2019 Fourth Quarter and Full Year Financial Results

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, reports financial results for the three and 12 months ended December 31, 2019 and provides a business update.

Mar 05, 2020 06:50 am ET

Ra Medical Systems Announces NYSE Acceptance of Compliance Plan

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that the New York Stock Exchange (the “NYSE”) has accepted the Company’s business plan to regain compliance with the NYSE continued listing standards.

Mar 03, 2020 06:50 am ET

Ra Medical Systems to Report 2019 Fourth Quarter and Full Year Financial Results on March 10, 2020

Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report 2019 fourth quarter and full year financial results and provide a business update after market close on Tuesday, March 10, 2020. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss finan

Feb 27, 2020 07:00 am ET

Ra Medical Systems Announces Enrollment of First Patient in Pivotal Atherectomy Clinical Study

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces enrollment of the first patient in its pivotal study to evaluate the safety and effectiveness of the DABRA excimer laser system for use as an atherectomy device for the treatment of peripheral vascular stenoses.

Jan 23, 2020 06:50 am ET

Ra Medical Systems to Showcase Pharos, Optimized Dermatology Excimer Laser at Two Upcoming Dermatology Conferences

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces it will be showcasing its Pharos, Optimized Dermatology Excimer Laser at two upcoming dermatology conferences.

Jan 21, 2020 06:50 am ET

Ra Medical Systems Receives FDA IDE Approval to Begin Pivotal Atherectomy Clinical Study

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces approval from the U.S. Food and Drug Administration (FDA) that the Company has provided sufficient data to support initiating an investigational device exemption (IDE) to evaluate the safety and effectiveness of the DABRA excimer laser system for use as an atherectomy device for the treatment of peripheral vascular stenoses. In May 2017, DABRA received FDA 510(k) clearance for use in ablating a channel in occlusive peripheral

Jan 07, 2020 07:00 am ET

Ra Medical Systems Names Dr. Chris Folk Vice President of Engineering

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces the appointment of Chris Folk, PhD, as Vice President of Engineering, effective January 13, 2020. With more than 20 years of engineering experience primarily in medtech, Dr. Folk has led the design, development and engineering of novel medical devices with highly specific design requirements, leading to commercial success. In this newly created position, Dr. Folk will report to

Dec 06, 2019 04:11 pm ET

Ra Medical Systems Receives NYSE Failure to Satisfy a Continued Listing Rule Notification

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, today announced that on December 4, 2019, it received a notice from the New York Stock Exchange (the “NYSE”) that it is not in compliance with a NYSE continued listing requirement for maintaining an average total market capitalization of not less than $50 million over a period of 30 consecutive trading days and having stockholders’ equity of not less than $50 million.

Nov 29, 2019 06:00 am ET

Ra Medical Systems Reports Third Quarter 2019 Financial Results

Nov 20, 2019 01:07 pm ET

Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of Ra Medical Systems, Inc. (RMED) on Behalf of Shareholders

Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors of Ra Medical Systems, Inc. (NYSE: RMED) violated federal securities law. Ra Medical Systems is a commercial-stage medical device company.

Oct 31, 2019 05:08 pm ET

Ra Medical Systems Announces Substantial Completion of Audit Committee Investigation

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, today announced that the Audit Committee of the Board of Directors (the “Audit Committee”) has substantially completed its internal investigation, which was originally announced in August. The Audit Committee, assisted by independent legal counsel, Morrison & Foerster LLP, conducted a thorough investigation of allegations raised by an employee, as well as additional matters discovered during the course of the investigation.

Oct 04, 2019 06:20 pm ET

WeissLaw LLP: Ra Medical Systems, Inc. is the Subject of a Legal Investigation

NEW YORK, Oct. 4, 2019 /PRNewswire/ -- WeissLaw LLP, a national class action and shareholders' rights law firm with offices in New York, Los Angeles and Atlanta, announces an investigation of Ra Medical Systems, Inc. (NYSE: RMED) ("RMED," or the "Company").

Aug 23, 2019 04:46 pm ET

Ra Medical Systems Receives NYSE Notice Related to Delay in Form 10-Q Filing

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, today announced that it received a notice from the NYSE indicating that Ra Medical is not in compliance with the NYSE’s continued listing requirements under the timely filing criteria established in Section 802.01E of the NYSE Listed Company Manual as a result of Ra Medical’s delay in filing its Quarterly Report on Form 10-Q for its quarter ended June 30, 2019 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”).

Aug 20, 2019 04:00 pm ET

RMED LOSS NOTICE: ROSEN, A LEADING LAW FIRM, Announces Investigation of Breaches of Fiduciary Duties By Management of Ra Medical Systems, Inc. – RMED

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the management of Ra Medical Systems, Inc. (NYSE: RMED) resulting from allegations that Ra Medical may have issued materially...

Aug 14, 2019 03:51 pm ET

EQUITY ALERT: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties By Management of Ra Medical Systems, Inc. – RMED

Aug 12, 2019 03:51 pm ET

Ra Medical Systems Reports Preliminary Second Quarter 2019 Financial Results

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, today reported certain preliminary results for the quarter ended June 30, 2019, as well as a leadership transition. Ra Medical also announced that it will delay its earnings release and investor conf

Aug 08, 2019 03:00 pm ET

FINAL DEADLINE ALERT - Ra Medical Systems, Inc. (RMED) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: August 9, 2019

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ra Medical Systems, Inc. (“Ra Medical” or the “Company”) (NYSE: RMED) and certain of its officers, on behalf of...

Aug 07, 2019 06:00 pm ET

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ra Medical Systems, Inc.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming August 9, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Ra Medical Systems, Inc. (“Ra Medical” or the “Company”) (NYSE: RMED) investors who...

Aug 07, 2019 02:58 pm ET

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ra Medical Systems, Inc.

Law Offices of Howard G. Smith reminds investors of the upcoming August 9, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Ra Medical Systems, Inc. (“Ra Medical” or the “Company”)...

Aug 06, 2019 10:00 am ET

SHAREHOLDER ALERT - Ra Medical Systems, Inc. (RMED) - Bronstein, Gewirtz & Grossman, LLC Alerts Shareholders of Class Action and Lead Plaintiff Deadline: August 9, 2019

NEW YORK, Aug. 6, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ra Medical Systems, Inc. ("Ra Medical" or the "Company") (NYSE: RMED) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Ra Medical securities pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's September 2018 initial public offering ("IPO" or the "Offering"). Such investors are en

Aug 06, 2019 09:56 am ET

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of RMED, RBGLY, GTT and CARB

The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...

Aug 06, 2019 08:35 am ET

TUESDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ra Medical Systems, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Fi

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ra Medical Systems, Inc. (“Ra Medical” or “the Company”) (NYSE: RMED) for violations of the federal securities laws....

Aug 05, 2019 08:07 pm ET

4-DAY RMED INVESTOR DEADLINE: Hagens Berman Reminds Ra Medical (RMED) Investors of August 9, 2019 Lead Plaintiff Deadline

Hagens Berman Sobol Shapiro LLP reminds investors in Ra Medical Systems, Inc. (NYSE: RMED) of the August 9, 2019 Lead Plaintiff deadline in the securities class action, Derr v. Ra Medical Systems, Inc. et al., 3:19-cv-01079, pending in the U.S....

Aug 05, 2019 06:04 pm ET

CLASS ACTION UPDATE for RMED, OMCL, KPTI and CURLF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...

Aug 05, 2019 10:23 am ET

FINAL DEADLINE: Rosen, a Top Ranked Law Firm, Reminds Investors of Ra Medical Systems, Inc. of August 6th Deadline in the Securities Class Action – RMED

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ra Medical Systems, Inc. (NYSE: RMED) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”)...

Aug 05, 2019 09:14 am ET

SHAREHOLDER ALERT: RMED CTST EGBN GTT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...

Aug 02, 2019 03:00 pm ET

Ra Medical Systems, Inc. (RMED), ChinaCache International Holdings Ltd. (CCIH) & Ideanomics Inc. (IDEX)– Class Action Update - Bronstein, Gewirtz & Grossman, LLC

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...

Aug 02, 2019 09:39 am ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of RMED, TEVA, RBGLY and EGBN

The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...

Aug 02, 2019 07:05 am ET

Pawar Law Group Reminds Investors of August 6 Deadline in Securities Class Action Lawsuit Against a Medical Systems, Inc. – RMED

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Ra Medical Systems, Inc. (NYSE: RMED) pursuant and/or traceable to the registration statement and prospectus (collectively, the...

Aug 01, 2019 09:30 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mammoth Energy, Pyxus International, Ra Medical, and ChinaCache International Holdings and Encourages I

Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Mammoth Energy Services, Inc., Pyxus International, Inc., Ra Medical Systems, Inc., and ChinaCache International Holdings Ltd....

Aug 01, 2019 08:07 pm ET

RMED INVESTOR ALERT: Hagens Berman Reminds Ra Medical (RMED) Investors of August 9, 2019 Lead Plaintiff Deadline; Investors Who Lost $50,000+ May Contact the Firm

Aug 01, 2019 04:59 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ra Medical Systems, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ra Medical Systems, Inc. (Ra Medical or the “Company”) (NYSE:RMED) of the August 6, 2019 deadline to seek the role of lead plaintiff in a federal securities class...

Aug 01, 2019 09:25 am ET

CLASS ACTION UPDATE for BOX, RMED, RLGY and OMCL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Jul 31, 2019 01:09 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ra Medical Systems, Inc. - RMED

Pomerantz LLP is investigating claims on behalf of investors of Ra Medical Systems, Inc. (“Ra Medical” or the “Company”) (NYSE: RMED). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....

Jul 31, 2019 09:08 am ET

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of RMED, CTST, OMCL and KPTI

Jul 30, 2019 08:11 pm ET

Hagens Berman Reminds Ra Medical (RMED) Investors of August 9, 2019 Lead Plaintiff Deadline, Investors Who Lost $50,000+ May Contact the Firm

Jul 30, 2019 09:22 am ET

7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ra Medical Systems, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Jul 29, 2019 01:53 pm ET

ROSEN, A TOP RANKED LAW FIRM, Reminds Investors of Ra Medical Systems, Inc. of August 6th Deadline in the Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Fi

Jul 26, 2019 03:00 pm ET

Pyxus International, Inc. f/k/a Alliance One International, Inc. (PYX), Ra Medical Systems, Inc. (RMED) & ChinaCache International Holdings Ltd. (CCIH) – Class Action Reminder

Jul 26, 2019 08:50 am ET

Ra Medical Systems Launches Pharos, Optimized Dermatology Excimer Laser

Ra Medical Systems, Inc. (NYSE: RMED) today announced the launch of Pharos, Optimized, the next generation

Jul 25, 2019 09:00 am ET

Notice of Lead Plaintiff Opportunity in Securities Case Filed on Behalf of Purchasers of Ra Medical Systems Inc. Securities

Robbins Geller Rudman & Dowd LLP announces that a securities class action case has been filed on behalf of purchasers of Ra Medical Systems, Inc. (NYSE:RMED) securities pursuant and/or traceable to the Company’s September 2018 initial public offering (“IPO”) in the U.S. District Court for the Southern District of California, captioned Derr

Jul 24, 2019 10:06 am ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of RMED, PYX, BUD and NFLX

Jul 23, 2019 09:30 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pyxus International, Ascena Retail Group, Ra Medical, and ChinaCache International Holdings and Encoura

Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Pyxus International, Inc., Ascena Retail Group, Inc., Ra Medical Systems, Inc., and ChinaCache International Holdings Ltd....

Jul 23, 2019 04:00 pm ET

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ra Medical Systems, Inc. To Contact The Firm

Jul 23, 2019 09:43 am ET

CLASS ACTION UPDATE for RMED, TEVA, FDX and RLGY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Jul 22, 2019 05:25 pm ET

Pawar Law Group Reminds Investors of August 6 Deadline in Securities Class Action Lawsuit Against Ra Medical Systems, Inc. – RMED

Jul 22, 2019 03:38 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ra Medical Systems, Inc. - RMED

Jul 22, 2019 11:30 am ET

UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ra Medical Systems, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the F

Jul 19, 2019 03:00 pm ET

Pyxus International, Inc. f/k/a Alliance One International, Inc. (PYX), Ra Medical Systems, Inc. (RMED) & ChinaCache International Holdings Ltd. (CCIH) - Bronstein, Gewirtz & Grossman, LLC Class Actio

Jul 19, 2019 09:21 am ET

SHAREHOLDER ALERT: MBNKF STG RMED INS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Jul 18, 2019 02:14 pm ET

You are here

(:RMED)

Business Focus: N/A